Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients.

Clinical imaging·2026
Same author

Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial.

Breast cancer research and treatment·2026
Same author

Erratum: Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

JCO precision oncology·2026
Same author

Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer.

Breast cancer research : BCR·2026
Same author

Development and evaluation of a cervical cancer-specific restriction spectrum imaging (RSI) model.

Magnetic resonance imaging·2026

Related Experiment Video

Updated: Jul 2, 2025

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

22.5K

Molecular Breast Imaging in the Screening Setting.

Katherine A Smith1, Katie N Hunt1, Gaiane M Rauch2,3

  • 1Mayo Clinic, Department of Radiology, Rochester, MN, USA.

Journal of Breast Imaging
|February 28, 2024
PubMed
Summary

Molecular breast imaging (MBI) offers a supplemental screening option for women with dense breast tissue, improving early breast cancer detection beyond mammography. Research shows MBI

Keywords:
99mTc-sestamibibreast cancer screeningbreast densitybreast-specific gamma imagingmolecular breast imaging

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.0K

Related Experiment Videos

Last Updated: Jul 2, 2025

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

22.5K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.0K

Area of Science:

  • Radiology and Imaging
  • Oncology
  • Nuclear Medicine

Background:

  • Mammography sensitivity for breast cancer detection is limited in women with dense breasts.
  • Supplemental screening modalities are crucial for early detection in this population.
  • Molecular breast imaging (MBI) is a functional imaging technique using 99mTc-sestamibi.

Approach:

  • This review synthesizes evidence on MBI as a supplemental screening tool.
  • It examines studies involving over 6000 women across four institutions since 2011.
  • A recent multicenter trial comparing digital breast tomosynthesis with and without MBI is discussed.

Key Points:

  • MBI identifies metabolically active breast areas, complementing mammography.
  • Six large studies support MBI's efficacy as a supplemental screen.
  • Ongoing research, including a large clinical trial, further evaluates MBI's role.

Conclusions:

  • MBI shows promise as an effective supplemental breast cancer screening method.
  • Its functional imaging capability addresses limitations of standard mammography in dense breasts.
  • Technological advancements continue to refine MBI's application in breast cancer detection.